Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Development and reliability of a correction factor for family-reported medication adherence: pediatric inflammatory bowel disease as an exemplar.

Wu YP, Pai AL, Gray WN, Denson LA, Hommel KA.

J Pediatr Psychol. 2013 Sep;38(8):893-901. doi: 10.1093/jpepsy/jst043. Epub 2013 Jun 26.

2.

Identifying youth nonadherence in clinical settings: data-based recommendations for children and adolescents with inflammatory bowel disease.

Greenley RN, Kunz JH, Biank V, Martinez A, Miranda A, Noe J, Telega G, Tipnis NA, Werlin S, Stephens MC.

Inflamm Bowel Dis. 2012 Jul;18(7):1254-9. doi: 10.1002/ibd.21859. Epub 2011 Aug 29.

PMID:
22689633
3.

Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease.

Hommel KA, Davis CM, Baldassano RN.

Inflamm Bowel Dis. 2009 Apr;15(4):589-93. doi: 10.1002/ibd.20798.

4.

Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy.

Modi AC, Guilfoyle SM, Morita DA, Glauser TA.

Epilepsia. 2011 Feb;52(2):370-6. doi: 10.1111/j.1528-1167.2010.02789.x. Epub 2010 Nov 18.

5.

Association of disease, adolescent, and family factors with medication adherence in pediatric inflammatory bowel disease.

Reed-Knight B, Lewis JD, Blount RL.

J Pediatr Psychol. 2011 Apr;36(3):308-17. doi: 10.1093/jpepsy/jsq076. Epub 2010 Aug 26.

PMID:
20798185
6.

Barriers to adherence among adolescents with inflammatory bowel disease.

Greenley RN, Stephens M, Doughty A, Raboin T, Kugathasan S.

Inflamm Bowel Dis. 2010 Jan;16(1):36-41. doi: 10.1002/ibd.20988.

PMID:
19434722
7.

May you never forget what is worth remembering: the relation between recall of medical information and medication adherence in patients with inflammatory bowel disease.

Linn AJ, van Dijk L, Smit EG, Jansen J, van Weert JC.

J Crohns Colitis. 2013 Dec;7(11):e543-50. doi: 10.1016/j.crohns.2013.04.001. Epub 2013 May 7.

PMID:
23660489
8.

Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease.

Hommel KA, Hente EA, Odell S, Herzer M, Ingerski LM, Guilfoyle SM, Denson LA.

Eur J Gastroenterol Hepatol. 2012 Jan;24(1):64-9. doi: 10.1097/MEG.0b013e32834d09f1.

9.

Oral medication adherence in pediatric inflammatory bowel disease.

Mackner LM, Crandall WV.

Inflamm Bowel Dis. 2005 Nov;11(11):1006-12.

PMID:
16239847
10.

Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease.

Kane S, Becker B, Harmsen WS, Kurian A, Morisky DE, Zinsmeister AR.

Am J Gastroenterol. 2012 Feb;107(2):154-60. doi: 10.1038/ajg.2011.317.

PMID:
22306937
11.

Individually tailored treatment of medication nonadherence.

Hommel KA, Herzer M, Ingerski LM, Hente E, Denson LA.

J Pediatr Gastroenterol Nutr. 2011 Oct;53(4):435-9. doi: 10.1097/MPG.0b013e3182203a91.

12.

Can You Teach a Teen New Tricks? Problem Solving Skills Training Improves Oral Medication Adherence in Pediatric Patients with Inflammatory Bowel Disease Participating in a Randomized Trial.

Greenley RN, Gumidyala AP, Nguyen E, Plevinsky JM, Poulopoulos N, Thomason MM, Walter JG, Wojtowicz AA, Blank E, Gokhale R, Kirschner BS, Miranda A, Noe JD, Stephens MC, Werlin S, Kahn SA.

Inflamm Bowel Dis. 2015 Nov;21(11):2649-57. doi: 10.1097/MIB.0000000000000530. Erratum in: Inflamm Bowel Dis. 2015 Nov;21(11):2657.

PMID:
26218142
13.

Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment.

Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, Hechtman L, Chuang S, Wells KC, Pelham W, Cooper T, Elliott G, Newcorn JH.

J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):501-10. doi: 10.1097/CHI.0b013e31819c23ed.

PMID:
19307987
14.

Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset.

Misdrahi D, Tessier A, Swendsen J, Berna F, Brunel L, Capdevielle D, Chereau I, Danion JM, De Pradier M, Dorey JM, Dubertret C, Dubreucq J, Faget C, Gabayet F, Rey R, Richieri R, Passerieux C, Schandrin A, Schurhoff F, Tronche AM, Urbach M, Llorca PM, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group.

J Clin Psychiatry. 2016 Sep;77(9):e1130-e1136. doi: 10.4088/JCP.15m10115.

PMID:
27780318
15.

Improving the measurement of self-reported medication nonadherence.

Voils CI, Hoyle RH, Thorpe CT, Maciejewski ML, Yancy WS Jr.

J Clin Epidemiol. 2011 Mar;64(3):250-4. doi: 10.1016/j.jclinepi.2010.07.014. Epub 2010 Dec 30.

16.

Comparison of methods to assess medication adherence and classify nonadherence.

Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD.

Ann Pharmacother. 2009 Mar;43(3):413-22. doi: 10.1345/aph.1L496. Epub 2009 Mar 3.

PMID:
19261962
17.

Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel Disease.

Gallinger ZR, Rumman A, Nguyen GC.

J Crohns Colitis. 2016 Aug;10(8):892-7. doi: 10.1093/ecco-jcc/jjw052. Epub 2016 Feb 19.

PMID:
26896087
18.

Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease.

Hommel KA, Baldassano RN.

J Pediatr Psychol. 2010 Oct;35(9):1005-10. doi: 10.1093/jpepsy/jsp126. Epub 2009 Dec 21.

19.

Validation of a contemporary adherence measure for children with Type 1 diabetes: the Diabetes Management Questionnaire.

Mehta SN, Nansel TR, Volkening LK, Butler DA, Haynie DL, Laffel LM.

Diabet Med. 2015 Sep;32(9):1232-8. doi: 10.1111/dme.12682. Epub 2015 Jan 30.

20.

Treatment adherence in paediatric inflammatory bowel disease: perceptions from adolescent patients and their families.

Hommel KA, Odell S, Sander E, Baldassano RN, Barg FK.

Health Soc Care Community. 2011 Jan;19(1):80-8. doi: 10.1111/j.1365-2524.2010.00951.x. Epub 2010 Sep 9.

Supplemental Content

Support Center